SURVIVAL TECHNOLOGY INC.
8101 Glenbrook Rd.
Bethesda, Md. 20814
FISCAL YEAR: July 31
REVENUE: $27.8 million
EARNINGS PER SHARE: 11 cents
STOCKHOLDERS' EQUITY: $6.3 million
RETURN ON EQUITY: 5.1 percent
ASSETS: $22.1 million
CHAIRMAN: Stanley J. Sarnoff
PRESIDENT: Stanley J. Sarnoff
DESCRIPTION: Survival Technology designs and manufactures a line of medical devices and services centered on its patented line of medical syringes. The syringes are prefilled "auto-injectors" that patients with a variety of medical conditions can administer to themselves.
DEVELOPMENTS: Over the past 30 years, Survival Technology has made 50 million of its special auto-injectors for the Pentagon, filled with an antidote to nerve gas to protect American soldiers on the battlefield. Defense work continued to dominate Survival Tech's revenue in 1987, with the firm winning a key $8 million extension of its contract in March.
But Survival Tech also made substantial progress in its attempt to expand its commercial product line. In January, the Food and Drug Administration approved the use of Survival Tech syringes filled with antidotes for people experiencing severe allergic reactions to a wide range of foods and drugs. Previously the firm had been able to market the "Epipen" only for insect allergies.
The FDA also gave a boost to Survival Tech by approving the blood clot dissolver TPA in November. Survival Tech has been working with that drug's manufacturer, Genentech, for two years to develop a version of the drug that heart attack victims can administer to themselves.